Literature DB >> 16307352

Anthranilic acid-uraemic toxin damaged red cell's membrane.

A Tankiewicz1, D Pawlak, K Pawlak, D Szewc, M Myśliwiec, W Buczko.   

Abstract

Normocytic normochromic anaemia is a common syndrome present in patients with chronic renal insufficiency (CRI). Simultaneously in these patients the increase in L-tryptophan (TRP) degradation via kynurenine pathway is observed. On the basis of these observations we tried to examine whether one of the TRP metabolites, anthranilic acid (AA), shows interaction with membranes of erythrocytes and because of that it may contribute to anaemia development. In patients with CRI we have observed changes characteristic for normocytic normochromic anaemia, such as the decrease in erythrocyte count, haemoglobin concentration, haematocrit and the decrease in erythrocyte osmotic resistance as well as the increase in AA concentration in plasma in comparison to healthy subjects. We have also noticed the existence of a positive correlation between anthranilic acid concentration and creatinine and urea concentrations and also negative relationships between anthranilic acid concentration and haematological parameters. Moreover, incubation of healthy erythrocytes with 10 and 100 microM AA caused haemolysis curve movement to the right, which shows decrease in osmotic resistance. In conclusion, the increase in plasma AA concentration might be one of many factors, which damage erythrocyte membrane, and thereby contributes to anaemia development in patients with CRI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307352     DOI: 10.1007/s11255-005-0395-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

Review 1.  Pathophysiologic effects of uremic retention solutes.

Authors:  R Vanholder; R De Smet
Journal:  J Am Soc Nephrol       Date:  1999-08       Impact factor: 10.121

2.  Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.

Authors:  D Pawlak; K Pawlak; J Malyszko; M Mysliwiec; W Buczko
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection.

Authors:  C Hervé; P Beyne; H Jamault; E Delacoux
Journal:  J Chromatogr B Biomed Appl       Date:  1996-01-12

4.  [Osmotic resistance in erythrocytes in patients with chronic renal insufficiency].

Authors:  M Jakić; V Rupcić; S Stipanić; V Slanovic
Journal:  Lijec Vjesn       Date:  1991 Nov-Dec

5.  Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.

Authors:  K Saito; S Fujigaki; M P Heyes; K Shibata; M Takemura; H Fujii; H Wada; A Noma; M Seishima
Journal:  Am J Physiol Renal Physiol       Date:  2000-09

6.  Reincorporated plasma membrane Ca2+-ATPase can mediate B-Type Ca2+ channels observed in native membrane of human red blood cells.

Authors:  C Pinet; S Antoine; A G Filoteo; J T Penniston; A Coulombe
Journal:  J Membr Biol       Date:  2002-06-01       Impact factor: 1.843

7.  Reduced erythrocyte defense mechanisms against free radical toxicity in patients with chronic renal failure.

Authors:  I Durak; O Akyol; E Başeşme; O Canbolat; M Kavutçu
Journal:  Nephron       Date:  1994       Impact factor: 2.847

8.  Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of glutathione metabolism.

Authors:  F Canestrari; F Galli; A Giorgini; M C Albertini; P Galiotta; M Pascucci; M Bossù
Journal:  Acta Haematol       Date:  1994       Impact factor: 2.195

Review 9.  Neuropharmacology of quinolinic and kynurenic acids.

Authors:  T W Stone
Journal:  Pharmacol Rev       Date:  1993-09       Impact factor: 25.468

10.  Kynurenines and the respiratory parameters on rat heart mitochondria.

Authors:  H Baran; K Staniek; B Kepplinger; J Stur; M Draxler; H Nohl
Journal:  Life Sci       Date:  2003-01-24       Impact factor: 5.037

View more
  5 in total

Review 1.  Normal and pathologic concentrations of uremic toxins.

Authors:  Flore Duranton; Gerald Cohen; Rita De Smet; Mariano Rodriguez; Joachim Jankowski; Raymond Vanholder; Angel Argiles
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

2.  The Toxicokinetic Profile of Dex40-GTMAC3-a Novel Polysaccharide Candidate for Reversal of Unfractionated Heparin.

Authors:  Emilia Sokolowska; Bartlomiej Kalaska; Kamil Kaminski; Alicja Lewandowska; Agnieszka Blazejczyk; Joanna Wietrzyk; Irena Kasacka; Krzysztof Szczubialka; Dariusz Pawlak; Maria Nowakowska; Andrzej Mogielnicki
Journal:  Front Pharmacol       Date:  2016-03-17       Impact factor: 5.810

3.  The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models.

Authors:  Malgorzata Karbowska; Tomasz W Kaminski; Natalia Marcinczyk; Tomasz Misztal; Tomasz Rusak; Lukasz Smyk; Dariusz Pawlak
Journal:  Toxins (Basel)       Date:  2017-07-19       Impact factor: 4.546

Review 4.  Kynurenine pathway in kidney diseases.

Authors:  Izabela Zakrocka; Wojciech Załuska
Journal:  Pharmacol Rep       Date:  2021-10-06       Impact factor: 3.919

5.  Kynurenine pathway metabolites predict subclinical atherosclerotic disease and new cardiovascular events in chronic kidney disease.

Authors:  Trista Benitez; Elizabeth VanDerWoude; Yun Han; Jaeman Byun; Vetalise Cheofor Konje; Brenda W Gillespie; Rajiv Saran; Anna V Mathew
Journal:  Clin Kidney J       Date:  2022-05-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.